Clinical Trial Update: Dorzagliatin and 1st Phase Insulin and Beta-cell Glucose Sensitivity in IGT and NGT [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on dorzagliatin assessing first-phase insulin response and beta-cell glucose sensitivity in individuals with glucose intolerance and norma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucose Intolerance

Drugs mentioned

• Dorzagliatin (dorzagliatin)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Glucose Intolerance | Phase 1, Phase 2 | Status: UNKNOWN